Literature DB >> 33514384

The effects of canola and olive oils consumption compared to sunflower oil, on lipid profile and hepatic steatosis in women with polycystic ovarian syndrome: a randomized controlled trial.

Maryam Yahay1,2, Zahra Heidari3, Zahra Allameh4, Reza Amani5,6.   

Abstract

BACKGROUND: Polycystic Ovarian Syndrome (PCOS) is one of the most common endocrinopathies and metabolic disorders in women during their reproductive years. It is often associated with dyslipidemia and other risk factors of cardiovascular diseases (CVD). This study was aimed to evaluate dietary intervention effects with canola and olive oils compared to sunflower oil on lipid profile and fatty liver severity among women with PCOS.
METHOD: This study was a 10-week intervention including 72 women with PCOS. Patients were randomly assigned to three groups for receiving 25 g/day canola, olive, or sunflower oils for 10 weeks. The primary and secondary outcomes were to assess changes in lipid profile and in fatty liver severity, respectively. RESULT: At the end of the study, 72 patients with a mean age of 29.31 were analysed. Canola oil consumption resulted in a significant reduction in serum levels of TG (P = 0.002) and TC/HDL (P = 0.021), LDL/HDL (P = 0.047), and TG/HDL (P = 0.001) ratios, however, there was no significant reduction in lipid profile following olive oil consumption. Canola (P < 0.001) and olive oils (P = 0.005) could significantly reduce the fatty liver grade. Moreover, HOMA-IR in both canola (P < 0.001) and olive (P = 0.004) groups was significantly decreased.
CONCLUSION: In total, compared to olive and sunflower oils, significant improvements in lipid profile, liver function, and HOMA-IR were observed following canola oil consumption in women with PCOS. TRIAL REGISTRATION: IR.MUI. RESEARCH: REC.1397.315. Registered 30 JUNE 2019 - Retrospectively registered, https://www.irct.ir/trial/38684.

Entities:  

Keywords:  Canola oil; Fatty liver; HOMA-IR; Lipid profile; Monounsaturated fatty acid; Olive oil; Polycystic ovary syndrome; Polyunsaturated fatty acid; SHBG

Year:  2021        PMID: 33514384     DOI: 10.1186/s12944-021-01433-9

Source DB:  PubMed          Journal:  Lipids Health Dis        ISSN: 1476-511X            Impact factor:   3.876


  83 in total

Review 1.  Androgen excess is the key element in polycystic ovary syndrome.

Authors:  Ricardo Azziz
Journal:  Fertil Steril       Date:  2003-08       Impact factor: 7.329

2.  Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome.

Authors:  Susanne Hahn; Onno E Janssen; Susanne Tan; Katja Pleger; Klaus Mann; Manfred Schedlowski; Rainer Kimmig; Sven Benson; Efthimia Balamitsa; Sigrid Elsenbruch
Journal:  Eur J Endocrinol       Date:  2005-12       Impact factor: 6.664

3.  Cardiovascular risk in women with polycystic ovary syndrome.

Authors:  Francesco Orio; Stefano Palomba; Annamaria Colao
Journal:  Fertil Steril       Date:  2006-07       Impact factor: 7.329

4.  Cardiovascular disease risk in women with PCOS.

Authors:  Anuja Dokras
Journal:  Steroids       Date:  2013-04-26       Impact factor: 2.668

Review 5.  Dyslipidemia and oxidative stress in PCOS.

Authors:  Djuro Macut; Jelica Bjekić-Macut; Ana Savić-Radojević
Journal:  Front Horm Res       Date:  2012-10-18       Impact factor: 2.606

6.  Black women with polycystic ovary syndrome (PCOS) have increased risk for metabolic syndrome and cardiovascular disease compared with white women with PCOS [corrected].

Authors:  Jennifer K Hillman; Lauren N C Johnson; Meghana Limaye; Rebecca A Feldman; Mary Sammel; Anuja Dokras
Journal:  Fertil Steril       Date:  2013-12-30       Impact factor: 7.329

Review 7.  Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment.

Authors:  Héctor F Escobar-Morreale
Journal:  Nat Rev Endocrinol       Date:  2018-03-23       Impact factor: 43.330

8.  Dyslipidemia in women with polycystic ovary syndrome: incidence, pattern and predictors.

Authors:  Michelle P Rocha; José A M Marcondes; Cristiano R G Barcellos; Sylvia A Y Hayashida; Daniela D G Curi; Ângela M da Fonseca; Vicente R Bagnoli; Edmund C Baracat
Journal:  Gynecol Endocrinol       Date:  2010-09-01       Impact factor: 2.260

9.  Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome.

Authors:  R A Wild; P C Painter; P B Coulson; K B Carruth; G B Ranney
Journal:  J Clin Endocrinol Metab       Date:  1985-11       Impact factor: 5.958

10.  The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis.

Authors:  Tao Ding; Paul J Hardiman; Irene Petersen; Fang-Fang Wang; Fan Qu; Gianluca Baio
Journal:  Oncotarget       Date:  2017-07-12
View more
  1 in total

1.  Olive Pomace Oil versus High Oleic Sunflower Oil and Sunflower Oil: A Comparative Study in Healthy and Cardiovascular Risk Humans.

Authors:  Susana González-Rámila; Raquel Mateos; Joaquín García-Cordero; Miguel A Seguido; Laura Bravo-Clemente; Beatriz Sarriá
Journal:  Foods       Date:  2022-07-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.